XSHG
600426
Market cap8.14bUSD
Oct 09, Last price
20.12CNY
1D
1.51%
1Q
8.00%
Jan 2017
97.41%
IPO
121.10%
Name
Shandong Haihua
Chart & performance
P/E
16.69
P/S
1.79
EPS
1.21
Div yield, %
2.77%
Shrs. gr., 5y
0.14%
Rev. gr., 5y
18.75%
Revenues
30.97b
-9.52%
Net income
3.32b
-15.04%
CFO
4.20b
-15.51%
Dividend
Jul 10, 20260.325 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shandong Hualu-Hengsheng Chemical Co., Ltd. manufactures and sells chemical products and raw materials worldwide. The company provides granular urea, power plant grade ammonium sulfate, caprolactam grade ammonium sulfate, and ammonium bicarbonate for agricultural use; and dimethyl carbonate, methyl ethyl carbonate, diethyl carbonate, and oxalic acid. It also offers glossy nylon 6 slices, caprolactam, adipic acid, melamine, N-butanol, isooctanol, N-butyraldehyde, isobutyraldehyde, ethylene glycol; dimethylformamide, monomethylamine, dimethylamine, trimethylamine, acetic acid, acetic anhydride, and methanol; autoclaved fly ash brick; nitrous oxide; and mixed diacids products. In addition, the company provides industrialization services, such as development planning, engineering design, project management, and equipment manufacturing. Shandong Hualu-Hengsheng Chemical Co., Ltd. was founded in 2000 and is based in Dezhou, China.
Key people
Yan Dong
Vice Chairman of the Board, Deputy General Manager · since 2012
Jinghong Gao
Finance Director, Secretary of the Board, Deputy General Manager · since 2012
Huaichun Chang
Chairman of the Board, General Manager · since 2018
Desheng Pan
Deputy General Manager · since 2010
Guangshan Zhuang
Deputy General Manager · since 2010
Yuanren Wang
Director · since 2012
Director · since 2015
Headquarters & legal address
山东省德州市天衢西路24号
德州市, SD 253000
CN
德州市, SD 253000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||